NIKKEI 225
38,439.24 -398.22 (-1.03%) HANG SENG
18,492.65 +48.54 (+0.26%) CRUDE OIL
73.18 -0.07 (-0.10%) GOLD FUTURES
2,358.00 +10.60 (+0.45%) DOW
38,711.29 +140.26 (+0.36%) Bitcoin GBP
55,548.52 +1,685.18 (+3.13%)
Baxter International Inc. (BAX)
After hours:
| Previous close | 34.08 |
| Open | 34.00 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 900 |
| Day's range | 33.24 - 34.16 |
| 52-week range | 31.01 - 50.21 |
| Volume | |
| Avg. volume | 3,882,887 |
| Market cap | 16.969B |
| Beta (5Y monthly) | 0.64 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.08 |
| Earnings date | 25 Jul 2024 - 29 Jul 2024 |
| Forward dividend & yield | 1.16 (3.48%) |
| Ex-dividend date | 31 May 2024 |
| 1y target est | 42.77 |
Simply Wall St.Baxter International (NYSE:BAX) Has Announced A Dividend Of $0.29
The board of Baxter International Inc. ( NYSE:BAX ) has announced that it will pay a dividend of $0.29 per share on the...
Business WireNew Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
DEERFIELD, Ill., May 29, 2024--Baxter International Inc. (NYSE:BAX), a global innovator in kidney care and vital organ support, today announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova dialyzer, was associated with an approximately 25% lower all-cause mortality risk for up to four years when compared to high-flux hemodialysis (HF HD). The study, "Survival of expanded hemodialysis and high-flux hemodialysis patients in Colombia: a cohort study," was prese
ZacksReasons to Retain Baxter International (BAX) in Your Portfolio Now
Baxter International's (BAX) robust growth across all geographies, along with transformational initiatives, boosts confidence. However, pandemic-related disruption continues to hurt sales.
